Table 3. The differential metabolites identified during rivaroxaban treatment of patients with nonvalvular atrial fibrillation.

ID	Name	Fold change	FDR	VIP	AUC
HMDB0031042	Avocadene	0.58456	4.68E−06	1.174606	0.73422
HMDB33630	Lactapiperanol C	0.64858	5.89E−05	1.098904	0.70969
	3,4,5-trihydroxy-6-{2-hydroxy-3-(4-hydroxy-3-methoxyphenyl)propanoyl}oxy}oxane-2-carboxylic acid	1.5116	2.14E−06	1.727014	0.78418
HMDB0031876	Prenyl glucoside	1.5329	1.53E−06	1.902436	0.79609
HMDB0009203	PE(18:4(6Z,9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z))	2.9346	1.83E−08	1.970988	0.82613
HMDB0029334	Nummularine B	3.3137	1.29E−08	1.96705	0.80569
HMDB34503	2,3,23-Triacetylsericic acid	3.7038	1.29E−08	1.89881	0.81049